{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T06:11:03Z","timestamp":1789193463687,"version":"build-2803163510"},"reference-count":46,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2011,6,1]],"date-time":"2011-06-01T00:00:00Z","timestamp":1306886400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,6,1]],"date-time":"2011-06-01T00:00:00Z","timestamp":1306886400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2013,8,22]],"date-time":"2013-08-22T00:00:00Z","timestamp":1377129600000},"content-version":"vor","delay-in-days":813,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Virology"],"published-print":{"date-parts":[[2011,6]]},"DOI":"10.1016\/j.virol.2011.03.016","type":"journal-article","created":{"date-parts":[[2011,4,18]],"date-time":"2011-04-18T13:23:26Z","timestamp":1303133006000},"page":"146-152","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":33,"title":["Treatment of mice with human monoclonal antibody 24 h after lethal aerosol challenge with virulent Venezuelan equine encephalitis virus prevents disease but not infection"],"prefix":"10.1016","volume":"414","author":[{"given":"Ann R.","family":"Hunt","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard A.","family":"Bowen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shana","family":"Frederickson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshiaki","family":"Maruyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John T.","family":"Roehrig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carol D.","family":"Blair","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.virol.2011.03.016_bb0005","doi-asserted-by":"crossref","first-page":"5922","DOI":"10.1016\/j.vaccine.2008.08.050","article-title":"First administration to humans of a monoclonal antibody cocktail against rabies virus: safety, tolerability, and neutralizing activity","volume":"26","author":"Bakker","year":"2008","journal-title":"Vaccine"},{"key":"10.1016\/j.virol.2011.03.016_bb0010","doi-asserted-by":"crossref","first-page":"2431","DOI":"10.1128\/AAC.01178-09","article-title":"Safety and pharmacokinetics of single intraveneous dose of MGAWM1, a novel monoclonal antibody to West Nile virus","volume":"54","author":"Beigel","year":"2010","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.virol.2011.03.016_bb0015","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1097\/00000441-200206000-00004","article-title":"Viral agents as biological weapons and agents of bioterrorism","volume":"323","author":"Bronze","year":"2002","journal-title":"Am. J. Med. Sci."},{"key":"10.1016\/j.virol.2011.03.016_bb0020","doi-asserted-by":"crossref","first-page":"333","DOI":"10.3201\/eid0808.010516","article-title":"Passive antibody administration (immediate immunity) as a specific defense against biological weapons","volume":"8","author":"Casadevall","year":"2002","journal-title":"Emerg. Infect. Dis."},{"key":"10.1016\/j.virol.2011.03.016_bb0025","first-page":"695","article-title":"Passive antibody therapy for infectious diseases","volume":"2","author":"Casadevall","year":"2004","journal-title":"Nat. Rev."},{"key":"10.1016\/j.virol.2011.03.016_bb0030","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1006\/viro.1996.8381","article-title":"Mucosal immunity induced by parenteral immunization with a live attenuated Venezuelan equine encephalitis virus vaccine candidate","volume":"228","author":"Charles","year":"1997","journal-title":"Virology"},{"key":"10.1016\/j.virol.2011.03.016_bb0035","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1006\/viro.2001.0878","article-title":"Immunopathogenesis and immune modulation of Venezuelan equine encephalitis virus-induced disease in the mouse","volume":"284","author":"Charles","year":"2001","journal-title":"Virology"},{"key":"10.1016\/j.virol.2011.03.016_bb0040","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1002\/jmv.10086","article-title":"Role for mucosal immune responses and cell-mediated immune functions in protection from airborne challenge with Venezuelan equine encephalitis virus","volume":"67","author":"Elvin","year":"2002","journal-title":"J. Med. Virol."},{"key":"10.1016\/j.virol.2011.03.016_bb0045","doi-asserted-by":"crossref","first-page":"3497","DOI":"10.1016\/j.vaccine.2008.04.044","article-title":"Neurovirulence evaluation of Venezuelan equine encephalitis (VEE) vaccine candidate V3526 in nonhuman primates","volume":"26","author":"Fine","year":"2008","journal-title":"Vaccine"},{"key":"10.1016\/j.virol.2011.03.016_bb0050","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1007\/s12026-009-8143-4","article-title":"Recovery from viral encephalomyelitis: immune-mediated noncytolytic virus clearance from neurons","volume":"47","author":"Griffin","year":"2010","journal-title":"Immunol. Res."},{"key":"10.1016\/j.virol.2011.03.016_bb0055","doi-asserted-by":"crossref","first-page":"3067","DOI":"10.1016\/S0264-410X(00)00042-6","article-title":"Improved mucosal protection against Venezuelan equine encephalitis virus is induced by the molecularly defined, live-attenuated v3526 vaccine candidate","volume":"18","author":"Hart","year":"2000","journal-title":"Vaccine"},{"key":"10.1016\/j.virol.2011.03.016_bb0060","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1146\/annurev.micro.55.1.235","article-title":"Biological weapons\u2014a primer for microbiologists","volume":"55","author":"Hawley","year":"2001","journal-title":"Annu. Rev. Microbiol."},{"key":"10.1016\/j.virol.2011.03.016_bb0065","doi-asserted-by":"crossref","first-page":"2467","DOI":"10.1099\/vir.0.81925-0","article-title":"A humanized murine monoclonal antibody protects mice either before or after challenge with virulent Venezuelan equine encephalomyelitis virus","volume":"87","author":"Hunt","year":"2006","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.virol.2011.03.016_bb0070","doi-asserted-by":"crossref","first-page":"e739","DOI":"10.1371\/journal.pntd.0000739","article-title":"The first human epitope map of the alphaviral E1 and E2 proteins reveals a new E2 epitope with significant virus neutralizing activity","volume":"4","author":"Hunt","year":"2010","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.virol.2011.03.016_bb0075","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1177\/030098589102800509","article-title":"Pathogenesis of Venezuelan equine encephalitis virus infection in mice and hamsters","volume":"28","author":"Jackson","year":"1991","journal-title":"Vet. Pathol."},{"key":"10.1016\/j.virol.2011.03.016_bb0080","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1128\/jcm.19.3.429-431.1984","article-title":"Protective efficacies of live attenuated and formaldehyde-inactivated Venezuelan equine encephalitis virus against aerosol challenge in hamsters","volume":"19","author":"Jahrling","year":"1984","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.virol.2011.03.016_bb0085","first-page":"79","article-title":"Venezuelan equine encephalitis","volume":"18","author":"Johnson","year":"1974","journal-title":"Adv. Vet. Sci. Comp."},{"key":"10.1016\/j.virol.2011.03.016_bb0090","series-title":"Virology","first-page":"843","article-title":"Alphaviruses","author":"Johnston","year":"1996"},{"key":"10.1016\/j.virol.2011.03.016_bb0095","doi-asserted-by":"crossref","first-page":"3005","DOI":"10.1099\/0022-1317-69-12-3005","article-title":"Recombinant vaccinia-Venezuelan equine encephalitis (VEE) virus expresses VEE structural proteins","volume":"69","author":"Kinney","year":"1988","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.virol.2011.03.016_bb0100","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1086\/514074","article-title":"summary of antibody workshop: the role of humoral immunity in the treatment and prevention of emerging and extant infectious diseases","volume":"176","author":"Krause","year":"1997","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.virol.2011.03.016_bb0105","doi-asserted-by":"crossref","first-page":"49","DOI":"10.4049\/jimmunol.96.1.49","article-title":"Pathogenesis of Venezuelan equine encephalomyelitis virus II. Infection in young and adult mice.","volume":"96","author":"Kundin","year":"1966","journal-title":"J. Immunol."},{"key":"10.1016\/j.virol.2011.03.016_bb0110","doi-asserted-by":"crossref","first-page":"6429","DOI":"10.1128\/jvi.66.11.6429-6435.1992","article-title":"Persistence of viral RNA in mouse brains after recovery from acute alphavirus encephalitis","volume":"66","author":"Levine","year":"1992","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2011.03.016_bb0115","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1126\/science.1658936","article-title":"Antibody-mediated clearance of alphavirus infection from neurons","volume":"254","author":"Levine","year":"1991","journal-title":"Science"},{"key":"10.1016\/j.virol.2011.03.016_bb0120","doi-asserted-by":"crossref","first-page":"2763","DOI":"10.4049\/jimmunol.129.6.2763","article-title":"Determination of the protective epitopes on the glycoproteins of Venezuelan equine encephalomyelitis virus by passive transfer of monoclonal antibodies","volume":"129","author":"Mathews","year":"1982","journal-title":"J. Immunol."},{"key":"10.1016\/j.virol.2011.03.016_bb0125","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1128\/jvi.55.3.594-600.1985","article-title":"Role of complement and the Fc portion of immunoglobulin G in immunity to Venezuelan equine encephalomyelitis virus infection with glycoprotein-specific monoclonal antibodies","volume":"55","author":"Mathews","year":"1985","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2011.03.016_bb0130","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1128\/jvi.19.3.985-997.1976","article-title":"Structural proteins of La Crosse virus","volume":"19","author":"Obijeski","year":"1976","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2011.03.016_bb0135","doi-asserted-by":"crossref","first-page":"2784","DOI":"10.1128\/JVI.80.6.2784-2796.2006","article-title":"Replication and clearance of Venezuelan equine encephalitis virus from the brains of animals vaccinated with chimeric SIN\/VEE viruses","volume":"80","author":"Paessler","year":"2006","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2011.03.016_bb0140","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.virusres.2006.02.003","article-title":"Venezuelan equine encephalitis virus complex-specific monoclonal antibody provides broad protection, in murine models, against airborne challenge with viruses from serogroups I II and III.","volume":"120","author":"Phillpotts","year":"2006","journal-title":"Virus Res."},{"key":"10.1016\/j.virol.2011.03.016_bb0145","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1016\/S0264-410X(01)00505-9","article-title":"Monoclonal antibody protects mice against infection and disease when given either before or up to 24h after airborne challenge with virulent Venezuelan equine encephalitis virus","volume":"20","author":"Phillpotts","year":"2002","journal-title":"Vaccine"},{"key":"10.1016\/j.virol.2011.03.016_bb0150","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/0264-410X(95)00168-Z","article-title":"Long-term duration of detectable neutralizing antibodies after administration of live-attenuated VEE vaccine and following booster vaccination with inactivated VEE vaccine","volume":"14","author":"Pittman","year":"1996","journal-title":"Vaccine"},{"key":"10.1016\/j.virol.2011.03.016_bb0155","doi-asserted-by":"crossref","first-page":"3854","DOI":"10.1016\/S0264-410X(03)00328-1","article-title":"Genetically engineered, live attenuated vaccines for Venezuelan equine encephalitis: testing in animal models","volume":"21","author":"Pratt","year":"2003","journal-title":"Vaccine"},{"key":"10.1016\/j.virol.2011.03.016_bb0160","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1093\/oxfordjournals.aje.a118408","article-title":"A simple method of estimating fifty percent endpoints","volume":"27","author":"Reed","year":"1938","journal-title":"Am. J. Epidem."},{"key":"10.1016\/j.virol.2011.03.016_bb0165","doi-asserted-by":"crossref","first-page":"3139","DOI":"10.1016\/j.vaccine.2004.12.023","article-title":"Genetically engineered, live, attenuated vaccines protect nonhuman primates against aerosol challenge with a virulent IE strain of Venezuelan equine encephalitis virus","volume":"23","author":"Reed","year":"2005","journal-title":"Vaccine"},{"key":"10.1016\/j.virol.2011.03.016_bb0170","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/0042-6822(80)90481-X","article-title":"Isolation and characterization of hybrid cell lines producing monoclonal antibodies directed against the structural proteins of Sindbis virus","volume":"101","author":"Roehrig","year":"1980","journal-title":"Virology"},{"key":"10.1016\/j.virol.2011.03.016_bb0175","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/0042-6822(82)90346-4","article-title":"Antigenic analysis of the surface glycoproteins of a Venezuelan equine encephalomyelitis virus (TC-83) using monoclonal antibodies","volume":"118","author":"Roehrig","year":"1982","journal-title":"Virology"},{"key":"10.1016\/j.virol.2011.03.016_bb0180","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/0042-6822(85)90343-5","article-title":"The neutralization site on the E2 glycoprotein of Venezuelan equine encephalomyelitis (TC-83) virus is composed of multiple conformationally stable epitopes","volume":"142","author":"Roehrig","year":"1985","journal-title":"Virology"},{"key":"10.1016\/j.virol.2011.03.016_bb0185","doi-asserted-by":"crossref","first-page":"2243","DOI":"10.1007\/BF01323243","article-title":"Spread of Venezuelan equine encephalitis virus in mice olfactory tract","volume":"140","author":"Ryzhikov","year":"1995","journal-title":"Arch. Virol."},{"key":"10.1016\/j.virol.2011.03.016_bb0190","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1006\/viro.2000.0276","article-title":"Synergistic interactions of antibodies in rate of virus neutralization","volume":"270","author":"Sanna","year":"2000","journal-title":"Virology"},{"key":"10.1016\/j.virol.2011.03.016_bb0195","first-page":"311","article-title":"Epidemiological studies on case of Venezuelan equine encephalomyelitis in a laboratory","volume":"4","author":"Slepushkin","year":"1959","journal-title":"Vop. Virulsol."},{"key":"10.1016\/j.virol.2011.03.016_bb0200","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.4269\/ajtmh.1980.29.1359","article-title":"Laboratory safety for arboviruses and certain other viruses of vertebrates","volume":"29","author":"The Subcommittee on Arbovirus Laboratory Safety of the American Committee on Arthropod-borne Viruses","year":"1980","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"10.1016\/j.virol.2011.03.016_bb0205","doi-asserted-by":"crossref","first-page":"1990","DOI":"10.1128\/jvi.69.3.1990-1993.1995","article-title":"Roles of immunoglobulin valency and the heavy-chain constant domain in antibody-mediated downregulation of Sindbis virus replication in persistently infected neurons","volume":"69","author":"Ubol","year":"1995","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2011.03.016_bb0210","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1146\/annurev.ento.49.061802.123422","article-title":"Venezuelan equine encephalitis","volume":"49","author":"Weaver","year":"2004","journal-title":"Annu. Rev. Entomol."},{"key":"10.1016\/j.virol.2011.03.016_bb0215","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/j.antiviral.2009.10.008","article-title":"Present and future arboviral threats","volume":"85","author":"Weaver","year":"2010","journal-title":"Antiviral Res."},{"key":"10.1016\/j.virol.2011.03.016_bb0220","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1128\/CMR.12.3.383","article-title":"Intranasal antibody prophylaxis for protection against viral disease","volume":"12","author":"Weltzin","year":"1999","journal-title":"Clin. Microbiol. Rev."},{"key":"10.1016\/j.virol.2011.03.016_bb0225","doi-asserted-by":"crossref","first-page":"894","DOI":"10.4269\/ajtmh.1968.17.894","article-title":"Contact-spread of Venezuelan equine encephalitis virus among cotton rats via urine or feces and the naso- or oropharynx A possible transmission cycle in nature.","volume":"17","author":"Zarate","year":"1968","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"10.1016\/j.virol.2011.03.016_bb0230","doi-asserted-by":"crossref","first-page":"54","DOI":"10.3201\/eid0501.990107","article-title":"Using monoclonal antibodies to prevent mucosal transmission of epidemic infectious diseases","volume":"5","author":"Zeitlin","year":"1999","journal-title":"Emerg. Inf. Dis."}],"container-title":["Virology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0042682211001413?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0042682211001413?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T00:12:05Z","timestamp":1758586325000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0042682211001413"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,6]]},"references-count":46,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2011,6]]}},"alternative-id":["S0042682211001413"],"URL":"https:\/\/doi.org\/10.1016\/j.virol.2011.03.016","relation":{},"ISSN":["0042-6822"],"issn-type":[{"value":"0042-6822","type":"print"}],"subject":[],"published":{"date-parts":[[2011,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Treatment of mice with human monoclonal antibody 24h after lethal aerosol challenge with virulent Venezuelan equine encephalitis virus prevents disease but not infection","name":"articletitle","label":"Article Title"},{"value":"Virology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.virol.2011.03.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2011 Elsevier Inc. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}